Polyplus-transfectionￃﾂￂﾮ Revenue and Competitors
Estimated Revenue & Valuation
- Polyplus-transfectionￃﾂￂﾮ's estimated annual revenue is currently $21.5M per year.
- Polyplus-transfectionￃﾂￂﾮ's estimated revenue per employee is $155,000
Employee Data
- Polyplus-transfectionￃﾂￂﾮ has 139 Employees.
- Polyplus-transfectionￃﾂￂﾮ grew their employee count by 13% last year.
Polyplus-transfectionￃﾂￂﾮ's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Field Application Specialist (Americas - West) | Reveal Email/Phone |
Polyplus-transfectionￃﾂￂﾮ Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $12.6M | 81 | -5% | N/A | N/A |
#2 | $19.5M | 126 | -2% | N/A | N/A |
#3 | $36.3M | 234 | 22% | N/A | N/A |
#4 | $19.7M | 127 | -17% | N/A | N/A |
#5 | $14.3M | 92 | 0% | $179.5M | N/A |
#6 | $49.4M | 208 | -8% | €201.1M | N/A |
#7 | $44.5M | 287 | -3% | N/A | N/A |
#8 | $7.6M | 49 | N/A | N/A | N/A |
#9 | $6.4M | 41 | N/A | N/A | N/A |
#10 | $17.2M | 111 | -15% | N/A | N/A |
What Is Polyplus-transfectionￃﾂￂﾮ?
Polyplus-transfection SA is a biotechnology company that develops, markets and sells innovative solutions for the in vivo, in vitro and ex vivo delivery of nucleic acids in research, bioproduction and therapeutics. Located close to the University of Strasbourg in Eastern France, Polyplus-transfection has been ISO 9001-certified since 2002 and supplies its proprietary range of reagents for the transfection of genes, oligonucleotides and siRNA through a worldwide distributor network. Polyplus reagents are involved in a growing number of clinical trials worldwide. In addition, Polyplus-transfection holds a broad estate of patents and licenses including original methods for therapeutic siRNA delivery.
keywords:N/A
N/A
Total Funding
139
Number of Employees
$21.5M
Revenue (est)
13%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Polyplus-transfectionￃﾂￂﾮ News
Polyplus-transfection SA, an Illkirch, France-based company that focuses on the development of innovative solutions for the delivery of nucleic acids in research and therapeutics, completed a €2.5m funding round. Investors include new shareholders AIRFI (Alsace Inter Regio Fonds d’Investissemen ...
Other Companies in
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | N/A | 139 | 72% | N/A |
#2 | $20.2M | 139 | N/A | N/A |
#3 | $29.2M | 139 | N/A | N/A |
#4 | $34.2M | 139 | N/A | N/A |
#5 | $20.2M | 139 | N/A | N/A |